Date post: September 11th, 2023 Date: 27/09/2023 On the 27th September, AEMPS is organising a multistakeholder meeting on repurposing and clinical data under the title: Repurposing and better use of Clinical Data, to promote the repurposing of medicinal products and how the better use of clinical data can help the repurposing of medicines in the […]
Date post: July 5th, 2023 Date: 26/09/2023 On the 26th September, AEMPS and the EU-Innovation Network (comprised of representatives from innovation offices within NCAs and EMA’s Innovation Task Force (ITF)) are organising a multistakeholder meeting on innovation under the title: Shaping a European innovation ecosystem: EU-Innovation Network multi-stakeholder meeting to promote research and development of […]
Formato pdf Fecha de publicación: 28 de enero de 2022 Categoría: medicamentos veterinarios Referencia: MVET, 02/2022 On January 28, 2022, Regulation (EU) 2019/6, of December 11 2018, of the European Parliament and Council, on veterinary medicinal products and repealing Directive 2001/82/EC, entry into force The Spanish Agency of Medicines and Medical Devices, as the competent […]
Formato pdf Date of update: 1st July 2020 Category: medicinal products of human use, COVID-19 Reference: MUH 04/2020 These measures are aimed at guaranteeing the trial activity, the safety and well-being of the patient and the traceability of the actions implemented They are complementary measures to those adopted recently in the EU and include the […]
Formato pdf Fecha de publicación: 16 de abril de 2020 Categoría: la AEMPS, COVID-19 Referencia: AEMPS, 14/2020 Se han celebrado dos workshops regulatorios virtuales sobre COVID19 en el marco de la Coalición Internacional de Autoridades Reguladoras de Medicamentos (ICMRA, por sus siglas en inglés). Ambos encuentros han permitido un acercamiento entre agencias reguladoras de medicamentos […]
Formato pdf Fecha de publicación: 16 de abril de 2020 Categoría: la AEMPS, COVID-19 Referencia: AEMPS, 14/2020 Se han celebrado dos workshops regulatorios virtuales sobre COVID19 en el marco de la Coalición Internacional de Autoridades Reguladoras de Medicamentos (ICMRA, por sus siglas en inglés). Ambos encuentros han permitido un acercamiento entre agencias reguladoras de medicamentos […]